antibodies agpa directed found within primary biliary cirrhosis pbc patients high frequency agpa recognize cytoplasmicoriented carboxyl terminus tail agpa found prognostic marker minority pbc patients higher mortality predicted poor addition patients responded ursodeoxycholic acid udca therapy therefore agpa reductions failed develop endstage liver disease relative untreated cohort pbc patients potentially destructive agpa increased expression bile duct potential immune toleranceescaping antimitochondrial antibodies also found pbc patients agpa progress toward endstage liver failure patients anticentromere antibodies often progress toward portal hypertension indicating specific role agpa pbc glycoprotein commonly used literature gene encodes nuclear pore nuclear porin major component human nuclear pore complex